These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7803523)

  • 21. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.
    Torrens M; Castillo C; San L; del Moral E; González ML; de la Torre R
    Drug Alcohol Depend; 1998 Nov; 52(3):193-200. PubMed ID: 9839145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma-hydroxybutyrate withdrawal syndrome.
    Dyer JE; Roth B; Hyma BA
    Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychosis in the context of sodium oxybate therapy.
    Langford J; Gross WL
    J Clin Sleep Med; 2011 Dec; 7(6):665-6. PubMed ID: 22171207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of heroin addicts using buprenorphine.
    Kosten TR; Morgan C; Kleber HD
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):119-28. PubMed ID: 1862786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Subjective wellbeing and somatic markers in methadone substitution. Evaluation of 61 heroin addicts].
    Giacomuzzi SM; Riemer Y; Kemmler G; Ertl M; Richter R; Rössler H; Hinterhuber H
    Fortschr Med Orig; 2001 Nov; 119(3-4):103-8. PubMed ID: 11789120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.
    San L; Camí J; Fernández T; Ollé JM; Peri JM; Torrens M
    Br J Addict; 1992 Jan; 87(1):55-62. PubMed ID: 1311974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methadone pseudowithdrawal syndrome: paradigm for a psychopharmacological model of opiate addiction.
    Whitehead CC
    Psychosom Med; 1974; 36(3):189-98. PubMed ID: 4829614
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of buspirone in withdrawal from opiates.
    Rose JS; Branchey M; Wallach L; Buydens-Branchey L
    Am J Addict; 2003; 12(3):253-9. PubMed ID: 12851021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
    J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma hydroxybutyric acid (GHB) intoxication.
    Mason PE; Kerns WP
    Acad Emerg Med; 2002 Jul; 9(7):730-9. PubMed ID: 12093716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary investigation of ibogaine: case reports and recommendations for further study.
    Sheppard SG
    J Subst Abuse Treat; 1994; 11(4):379-85. PubMed ID: 7966509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effectiveness of combined naloxone/lofexidine in opiate detoxification: results from a double-blind randomized and placebo-controlled trial.
    Beswick T; Best D; Bearn J; Gossop M; Rees S; Strang J
    Am J Addict; 2003; 12(4):295-305. PubMed ID: 14504022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial.
    Zarghami M; Masoum B; Shiran MR
    J Addict Dis; 2012; 31(2):112-7. PubMed ID: 22540433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stabilizing the social and health status of drug dependent patients with methadone. Long-term maintainance therapy--Vienna results].
    Loimer N; Werner E; Hollerer E; Pfersmann V; Schmid-Siegel B; Presslich O
    Wien Med Wochenschr; 1991; 141(14):325-9. PubMed ID: 1949832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients.
    San L; Fernandez T; Cami J; Gossop M
    J Subst Abuse Treat; 1994; 11(5):463-9. PubMed ID: 7869468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group.
    Addolorato G; Castelli E; Stefanini GF; Casella G; Caputo F; Marsigli L; Bernardi M; Gasbarrini G
    Alcohol Alcohol; 1996 Jul; 31(4):341-5. PubMed ID: 8879280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma-hydroxybutyric acid in the treatment of alcohol and heroin dependence.
    Gallimberti L; Spella MR; Soncini CA; Gessa GL
    Alcohol; 2000 Apr; 20(3):257-62. PubMed ID: 10869867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.